Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

Respiratory Laryngeal Dystonia: Characterization and Diagnosis of a Rare Neurogenic Disorder.

Tierney WS, Bryson PC, Nelson R, Kaplan SE, Benninger MS, Milstein CF.

Laryngoscope. 2020 Feb 19. doi: 10.1002/lary.28559. [Epub ahead of print]

PMID:
32073668
2.

A cough that won't go away: Evaluation and treatment in 2 patients.

Lee MY, Taliercio RM, Adessa M, Milstein C, Bryson PC.

Cleve Clin J Med. 2020 Feb;87(2):83-89. doi: 10.3949/ccjm.87a.19010. No abstract available.

3.

Benign Vocal Fold Lesions in Patients with Chronic Cough.

Adessa M, Xiao R, Hull D, Bowen AJ, Milstein CF, Benninger MS, Bryson PC.

Otolaryngol Head Neck Surg. 2020 Jan 21:194599819900505. doi: 10.1177/0194599819900505. [Epub ahead of print]

PMID:
31959050
4.

Exercise-induced laryngeal obstruction (EILO) in children and young adults: From referral to diagnosis.

Shay EO, Sayad E, Milstein CF.

Laryngoscope. 2019 Sep 9. doi: 10.1002/lary.28276. [Epub ahead of print]

PMID:
31498449
5.

Laryngeal Botulinum Toxin Injection for Vocal Tremor: Utility of Concurrent Strap Muscle Injection.

Nelson RC, Silva Merea V, Tierney WS, Milstein C, Benninger MS, Bryson PC.

Laryngoscope. 2019 Jun;129(6):1433-1437. doi: 10.1002/lary.27631. Epub 2018 Dec 27.

PMID:
30588631
6.

Tachyphylaxis and Dependence in Pharmacotherapy for Unexplained Chronic Cough.

Bowen AJ, Huang TL, Nowacki AS, Trask D, Kaltenbach J, Taliercio R, Benninger MS, Milstein CF, Bryson PC.

Otolaryngol Head Neck Surg. 2018 Oct;159(4):705-711. doi: 10.1177/0194599818788062. Epub 2018 Jul 17.

PMID:
30016197
7.

Short- and Long-term Effects of Neuromodulators for Unexplained Chronic Cough.

Bowen AJ, Nowacki AS, Contrera K, Trask D, Kaltenbach J, Milstein CF, Adessa M, Benninger MS, Taliercio R, Bryson PC.

Otolaryngol Head Neck Surg. 2018 Sep;159(3):508-515. doi: 10.1177/0194599818768517. Epub 2018 Apr 10.

PMID:
29634404
8.

Treatment of laryngopharyngeal reflux using a sleep positioning device: A prospective cohort study.

Tierney WS, Gabbard SL, Milstein CF, Benninger MS, Bryson PC.

Am J Otolaryngol. 2017 Sep - Oct;38(5):603-607. doi: 10.1016/j.amjoto.2017.06.012. Epub 2017 Jun 27.

PMID:
28688630
9.

Prevalence and Occupation of Patients Presenting With Dysphonia in the United States.

Benninger MS, Holy CE, Bryson PC, Milstein CF.

J Voice. 2017 Sep;31(5):594-600. doi: 10.1016/j.jvoice.2017.01.011. Epub 2017 Apr 13.

PMID:
28416083
10.

Paradoxical vocal fold motion (PVFM) in pediatric otolaryngology.

Smith B, Milstein C, Rolfes B, Anne S.

Am J Otolaryngol. 2017 Mar - Apr;38(2):230-232. doi: 10.1016/j.amjoto.2017.01.027. Epub 2017 Jan 24.

PMID:
28139319
11.

The Use of Cryotherapy for Papilloma and Early Laryngeal Cancers: Long-term Results.

Benninger MS, Derakhshan A, Milstein CF.

Ann Otol Rhinol Laryngol. 2015 Jul;124(7):509-14. doi: 10.1177/0003489414566266. Epub 2015 Jan 8.

PMID:
25573394
12.

Laryngeal reinnervation after vagal paraganglioma resection: a case report.

Lamarre ED, Lorenz RR, Milstein C, Scharpf J.

Am J Otolaryngol. 2011 Mar-Apr;32(2):171-3. doi: 10.1016/j.amjoto.2009.11.007. Epub 2010 Apr 13. No abstract available.

PMID:
20392529
13.

Ansa cervicalis-to-recurrent laryngeal nerve anastomosis for unilateral vocal fold paralysis: experience of a single institution.

Lorenz RR, Esclamado RM, Teker AM, Strome M, Scharpf J, Hicks D, Milstein C, Lee WT.

Ann Otol Rhinol Laryngol. 2008 Jan;117(1):40-5.

PMID:
18254370
14.

Results of ansa to recurrent laryngeal nerve reinnervation.

Lee WT, Milstein C, Hicks D, Akst LM, Esclamado RM.

Otolaryngol Head Neck Surg. 2007 Mar;136(3):450-4.

PMID:
17321876
15.

Vocal outcomes after laser resection of early-stage glottic cancer with adjuvant cryotherapy.

Knott PD, Milstein CF, Hicks DM, Abelson TI, Byrd MC, Strome M.

Arch Otolaryngol Head Neck Surg. 2006 Nov;132(11):1226-30.

PMID:
17116819
16.

Pillars Article: Origin of antibody variation. Nature 1966. 211: 242-243.

Brenner S, Milstein C.

J Immunol. 2006 Oct 1;177(7):4237-8. No abstract available.

17.

Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study.

Swoger J, Ponsky J, Hicks DM, Richter JE, Abelson TI, Milstein C, Qadeer MA, Vaezi MF.

Clin Gastroenterol Hepatol. 2006 Apr;4(4):433-41.

PMID:
16616347
18.

Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians.

Ahmed TF, Khandwala F, Abelson TI, Hicks DM, Richter JE, Milstein C, Vaezi MF.

Am J Gastroenterol. 2006 Mar;101(3):470-8.

PMID:
16542282
19.

Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope).

Milstein CF, Charbel S, Hicks DM, Abelson TI, Richter JE, Vaezi MF.

Laryngoscope. 2005 Dec;115(12):2256-61.

PMID:
16369176
20.

Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux.

Qadeer MA, Swoger J, Milstein C, Hicks DM, Ponsky J, Richter JE, Abelson TI, Vaezi MF.

Laryngoscope. 2005 Nov;115(11):1947-52.

PMID:
16319603
21.

Long-term effects of micronized Alloderm injection for unilateral vocal fold paralysis.

Milstein CF, Akst LM, Hicks MD, Abelson TI, Strome M.

Laryngoscope. 2005 Sep;115(9):1691-6.

PMID:
16148719
22.

From the structure of antibodies to the diversification of the immune response.

Milstein C.

Biosci Rep. 2004 Aug-Oct;24(4-5):280-301. No abstract available.

PMID:
16134016
23.

Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.

Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, Vaezi MF.

Laryngoscope. 2005 Jul;115(7):1230-8.

PMID:
15995512
24.

Continuous cultures of fused cells secreting antibody of predefined specificity. 1975.

Köhler G, Milstein C.

J Immunol. 2005 Mar 1;174(5):2453-5. No abstract available.

25.

The effects of lung volume initiation on speech: a perceptual study.

Milstein CF, Watson PJ.

J Voice. 2004 Mar;18(1):38-45.

PMID:
15070222
26.

AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization.

Rada C, Jarvis JM, Milstein C.

Proc Natl Acad Sci U S A. 2002 May 14;99(10):7003-8.

27.

Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination.

Ehrenstein MR, Rada C, Jones AM, Milstein C, Neuberger MS.

Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14553-8. Epub 2001 Nov 20.

28.
29.

Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography.

Karadimitris A, Gadola S, Altamirano M, Brown D, Woolfson A, Klenerman P, Chen JL, Koezuka Y, Roberts IA, Price DA, Dusheiko G, Milstein C, Fersht A, Luzzatto L, Cerundolo V.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3294-8.

30.

Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatography.

Altamirano MM, Woolfson A, Donda A, Shamshiev A, Briseño-Roa L, Foster NW, Veprintsev DB, De Libero G, Fersht AR, Milstein C.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3288-93.

31.

In vivo and in vitro studies of immunoglobulin gene somatic hypermutation.

Sale JE, Bemark M, Williams GT, Jolly CJ, Ehrenstein MR, Rada C, Milstein C, Neuberger MS.

Philos Trans R Soc Lond B Biol Sci. 2001 Jan 29;356(1405):21-8. Review.

32.

The molecular biology of CD1.

Calabi F, Milstein C.

Semin Immunol. 2000 Dec;12(6):503-9. Review.

PMID:
11145855
33.

Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease.

Carmichael J, Chatellier J, Woolfson A, Milstein C, Fersht AR, Rubinsztein DC.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9701-5.

34.

With the benefit of hindsight.

Milstein C.

Immunol Today. 2000 Aug;21(8):359-64. Review.

PMID:
10916137
35.

Memory in the B-cell compartment: antibody affinity maturation.

Neuberger MS, Ehrenstein MR, Rada C, Sale J, Batista FD, Williams G, Milstein C.

Philos Trans R Soc Lond B Biol Sci. 2000 Mar 29;355(1395):357-60. Review.

36.

The hybridoma revolution: an offshoot of basic research.

Milstein C.

Bioessays. 1999 Nov;21(11):966-73.

PMID:
10517870
37.

Optimism after much pessimism: what next?

Milstein C, Waldmann H.

Curr Opin Immunol. 1999 Oct;11(5):589-91. No abstract available.

PMID:
10508713
38.

Inhibition of apoptosis of a PARP(-)/(-)cell line transfected with PARP DNA-binding domain mutants.

Aoufouchi S, Yélamos J, Milstein C.

J Mol Biol. 1999 Jul 30;290(5):943-9.

PMID:
10438594
39.

The estimation of signal-to-noise ratio in continuous speech for disordered voices.

Qi Y, Hillman RE, Milstein C.

J Acoust Soc Am. 1999 Apr;105(4):2532-5. No abstract available.

PMID:
10212434
40.

Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting.

Rada C, Ehrenstein MR, Neuberger MS, Milstein C.

Immunity. 1998 Jul;9(1):135-41.

41.

Both DNA strands of antibody genes are hypermutation targets.

Milstein C, Neuberger MS, Staden R.

Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8791-4.

42.

Just noticeable differences for glottal flow waveform characteristics.

Scherer RC, Arehart KH, Guo CG, Milstein CF, Horii Y.

J Voice. 1998 Mar;12(1):21-30.

PMID:
9619976
43.
44.

Monitoring and interpreting the intrinsic features of somatic hypermutation.

Neuberger MS, Ehrenstein MR, Klix N, Jolly CJ, Yélamos J, Rada C, Milstein C.

Immunol Rev. 1998 Apr;162:107-16. Review.

PMID:
9602357
45.

Object-oriented modeling and terminologies for drug contraindications.

Liu JH, Milstein C, Séné B, Venot A.

Methods Inf Med. 1998 Jan;37(1):45-52.

PMID:
9550846
46.

Indicators for the automated analysis of drug prescribing quality.

Coste J, Séné B, Milstein C, Bouée S, Venot A.

Methods Inf Med. 1998 Jan;37(1):38-44.

PMID:
9550845
48.
49.

Cells strongly expressing Ig(kappa) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers.

Goyenechea B, Klix N, Yélamos J, Williams GT, Riddell A, Neuberger MS, Milstein C.

EMBO J. 1997 Jul 1;16(13):3987-94.

50.

Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation.

Goyenechea B, Milstein C.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13979-84. Erratum in: Proc Natl Acad Sci U S A 1997 May 27;94(11):5979.

Supplemental Content

Loading ...
Support Center